Position in GILD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$307,006
-$48,387 QoQ
Shares Held
2,430
-4.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,633
of 2,266 holders
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Advisory Alpha, LLC holds $20,079,575 across 8 Drug Manufacturers - General names. GILD ranks #8 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,238 | $8,681,475 | |
| 2 | JNJ |
Johnson & Johnson
|
22,094 | $5,611,213 | |
| 3 | ABBV |
AbbVie Inc.
|
9,774 | $2,459,529 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,797 | $1,130,414 | |
| 5 | PFE |
Pfizer Inc
|
42,927 | $1,033,682 | |
| 6 | AMGN |
Amgen Inc
|
1,326 | $480,171 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,527 | $376,085 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
2,430 | $307,006 |
All Filings in GILD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $307,006 | 2,430 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $355,393 | 2,550 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $299,976 | 2,444 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $287,046 | 2,586 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $375,294 | 3,385 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $396,208 | 3,536 | Shares | Sole | 2025-05-19 | |
| 2024-12-31 | $260,021 | 2,815 | Shares | Sole | 2025-01-17 | |
| 2020-09-30 | $27,866 | 441 | Shares | Sole | 2020-11-16 | |
| 2020-03-31 | $38,501 | 515 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||